Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-07-25

Clinical Trial Update: Introduction of Eurartesim® in Burkina Faso, Mozambique, Ghana and Tanzania

View source ↗

Summary

INDEPTH Network reports the introduction of Eurartesim for malaria in Burkina Faso, Mozambique, Ghana, and Tanzania.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Eurartesim (piperaquine tetraphosphate; artenimol)

Snippet

Sponsor: INDEPTH Network | Conditions: Malaria | Status: UNKNOWN